Daniel Loeb - Third Point
Holding/activity history for Nektar Therapeutics (NKTR)
← All NKTR superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2006 Q3 | 0 | 0.00 | Sell 100.00% | 1.27 | $190.65–278.25 · VW $239.80i | SEC | |
| 2006 Q2 | 63,333 | 1.27 | Add 90.00% | 0.60 | $248.25–348.00 · VW $298.78i | $17,423,000 | SEC |
| 2006 Q1 | 33,333 | 0.55 | Reduce 9.09% | 0.05 | $240.45–333.75 · VW $297.24i | $10,190,000 | SEC |
| 2005 Q4 | 36,667 | 0.50 | Add 10.00% | 0.05 | $204.45–262.80 · VW $238.04i | $9,053,000 | SEC |
| 2005 Q3 | 33,333 | 0.30 | Buy | 0.30 | $238.65–322.80 · VW $271.06i | $8,475,000 | SEC |